Insight into the binding of ACE-inhibitory peptides to angiotensin-converting enzyme: a molecular simulation

References

• Akif M, Georgiadis D, Mahajan A, et al. High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs. J Mol Biol. 2010;400(3):502–517. doi: 10.1016/j.jmb.2010.05.024
   PubMed Web of Science ®Google Scholar
• Bernstein KE, Khan Z, Giani JF, et al. Angiotensin-converting enzyme in innate and adaptive immunity. Nat Rev Nephrol. 2018;14:325–336. doi: 10.1038/nrneph.2018.15
   PubMed Web of Science ®Google Scholar
• Natesh R, Schwager SL, Sturrock ED, et al. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003;421(6922):551–554. doi: 10.1038/nature01370
   PubMed Web of Science ®Google Scholar
• Woodman ZL, Schwager SLU, Redelinghuys P, et al. Homologous substitution of ACE C-domain regions with N-domain sequences: Effect on processing, shedding, and catalytic properties. Biol Chem. 2006;387:1043–1051. doi: 10.1515/BC.2006.129
   PubMed Web of Science ®Google Scholar
• Akif M, Schwager SL, Anthony CS, et al. Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. Biochem J. 2011;436(1):53–59. doi: 10.1042/BJ20102123
   PubMedGoogle Scholar
• Fuchs S, Xiao HD, Hubert C, et al. Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo. Hypertension. 2008;51(2):267–274. doi: 10.1161/HYPERTENSIONAHA.107.097865
   PubMed Web of Science ®Google Scholar
• Bangalore S, Fakheri R, Wandel S, et al. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials. BMJ. 2017;356:j4. doi: 10.1136/bmj.j4
   PubMedGoogle Scholar
• Ondetti M, Rubin B, Cushman D. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977;196(4288):441–444. doi: 10.1126/science.191908
   PubMed Web of Science ®Google Scholar
• Sidorenkov G, Navis G. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13(10):1383–1395. doi: 10.1517/14740338.2014.951328
   PubMed Web of Science ®Google Scholar
• Alderman CP. Adverse Effects of the Angiotensin-Converting Enzyme Inhibitors. Ann Pharmacother. 2016;30(1):55–61. doi: 10.1177/106002809603000110
   Google Scholar
• Daskaya-Dikmen C, Yucetepe A, Karbancioglu-Guler F, et al. Angiotensin-I-converting enzyme (ACE)-inhibitory peptides from plants. Nutrients. 2017;9(4).316 doi: 10.3390/nu9040316
   PubMed Web of Science ®Google Scholar
• He R, Aluko RE, Ju XR. Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme. PLoS ONE. 2014;9(3).
   Web of Science ®Google Scholar
• Jalkute CB, Barage SH, Dhanavade MJ, et al. Molecular dynamics simulation and molecular docking studies of angiotensin converting enzyme with inhibitor lisinopril and amyloid beta peptide. Protein J. 2013;32(5):356–364. doi: 10.1007/s10930-013-9492-3
   PubMed Web of Science ®Google Scholar
• liang Xie C, young Choung S, ping Cao G, et al. In silico investigation of action mechanism of four novel angiotensin-I converting enzyme inhibitory peptides modified with Trp. J Funct Foods. 2015;17:632–639. doi: 10.1016/j.jff.2015.06.016
   Web of Science ®Google Scholar
• Nawaz K, David S, Murugesh E, et al. Identification and in silico characterization of a novel peptide inhibitor of angiotensin converting enzyme from pigeon pea ( Cajanus cajan ). Phytomedicine. 2017;36:1–7. doi: 10.1016/j.phymed.2017.09.013
   PubMed Web of Science ®Google Scholar
• Pan D, Guo H, Zhao B, et al. The molecular mechanisms of interactions between bioactive peptides and angiotensin-converting enzyme. Bioorg Med Chem Lett. 2011;21(13):3898–3904. doi: 10.1016/j.bmcl.2011.05.033
   PubMed Web of Science ®Google Scholar
• Wang M, Nie Y, Peng Y, et al. Purification, characterization and antitumor activities of a new protein from Syngnathus acus, an officinal marine fish. Mar Drugs. 2012;10(12):35–50. doi: 10.3390/md10010035
   PubMedGoogle Scholar
• Khan SB, Qian ZJ, Ryu BM, et al. Isolation and biochemical characterization of collagens from seaweed pipefish, Syngnathus schlegeli. Biotechnol Bioprocess Eng. 2009;14(4):436–442. doi: 10.1007/s12257-009-0007-1
   Web of Science ®Google Scholar
• Wijesekara I, Qian ZJ, Ryu B, et al. Purification and identification of antihypertensive peptides from seaweed pipefish (Syngnathus schlegeli) muscle protein hydrolysate. Food Res Int. 2011;44(3):703–707. doi: 10.1016/j.foodres.2010.12.022
   Web of Science ®Google Scholar
• DeLano WL. The PyMOL molecular graphics system. Schrödinger LLC. 2002;Version 2.0. Available from: http://www.pymol.org.
   Google Scholar
• Hess B, Kutzner C, Van Der Spoel D, et al. GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4(3):435–447. doi: 10.1021/ct700301q
   PubMed Web of Science ®Google Scholar
• Santos-Martins D, Forli S, Ramos MJ, et al. AutoDock4Zn: an improved AutoDock force field for small-molecule docking to zinc metalloproteins. J Chem Inf Model. 2014;54(8):2371–2379. doi: 10.1021/ci500209e
   PubMedGoogle Scholar
• Morris G, Huey R. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791. doi: 10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Lindorff-Larsen K, Piana S, Palmo K, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78(8):1950–1958.
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–935. doi: 10.1063/1.445869
   Web of Science ®Google Scholar
• Jones JE. On the Determination of Molecular Fields. II. From the Equation of State of a Gas. Proc R Soc Lond A. 1924;106(738):463–477. doi: 10.1098/rspa.1924.0082
   Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092. doi: 10.1063/1.464397
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, et al. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463–1472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Parrinello M, Rahman a. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182–7190. doi: 10.1063/1.328693
   Web of Science ®Google Scholar
• Costescu BI, Gr&quote;ater F. Time-resolved force distribution analysis. BMC Biophys. 2013;6:5. doi: 10.1186/2046-1682-6-5
   PubMed Web of Science ®Google Scholar
• Stacklies W, Xia F, Gr&quote;ater F. Dynamic allostery in the methionine repressor revealed by force distribution analysis. PLoS Comput Biol. 2009;5(11). doi: 10.1371/journal.pcbi.1000574
   Web of Science ®Google Scholar
• Kumari R, Kumar R, Lynn A. G-mmpbsa – a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54(7):1951–1962. doi: 10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Baker NA, Sept D, Joseph S, et al. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98(18):10037–10041. doi: 10.1073/pnas.181342398
   PubMed Web of Science ®Google Scholar
• Watermeyer JM, Sewell BT, Schwager SL, et al. Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry. 2006;45(42):12654–12663. doi: 10.1021/bi061146z
   PubMed Web of Science ®Google Scholar
• Voronov SV, Binevski PV, Zueva NA, et al. Structural and functional peculiarities of homologous domains of angiotensin-converting enzyme. Russ J Bioorganic Chem. 2003;29(5):426–433. doi: 10.1023/A:1026045324442
   Web of Science ®Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778–2786. doi: 10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Al Shukor N, Van Camp J, Gonzales GB, et al. Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships. J Agric Food Chem. 2013;61(48):11832–11839. doi: 10.1021/jf404641v
   PubMed Web of Science ®Google Scholar
• Rawendra RDS, Aisha Chang CI, et al. A novel angiotensin converting enzyme inhibitory peptide derived from proteolytic digest of Chinese soft-shelled turtle egg white proteins. J Proteom. 2013;94:359–369. doi: 10.1016/j.jprot.2013.10.006
   PubMed Web of Science ®Google Scholar
• Natesh R, Schwager SL, Evans HR, et al. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. 2004;43(27):8718–8724. doi: 10.1021/bi049480n
   PubMed Web of Science ®Google Scholar
• Wei L, Clauser E, Alhene-Gelas F, et al. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem. 1992;267(19):13398–13405.
   PubMed Web of Science ®Google Scholar
• Ehlers MR, Riordan JF. Angiotensin-converting enzyme: Zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry. 2002;30(29):7118–7126. doi: 10.1021/bi00243a012
   Google Scholar
• Yamamoto D, Takai S, Miyazaki M. Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site. Biochem Biophys Res Commun. 2007;354(4):981–984. doi: 10.1016/j.bbrc.2007.01.088
   PubMed Web of Science ®Google Scholar
• Brew K. Structure of human ACE gives new insights into inhibitor binding and design. Trends Pharmacol Sci. 2003;24(8):391–394. doi: 10.1016/S0165-6147(03)00196-2
   PubMed Web of Science ®Google Scholar